α-tocopherol succinate protects mice against radiation-induced gastrointestinal injury

Radiation Research

Volumn 177, Issue 2, 2012, Pages 133-145

  Singh, Pankaj K ^a   Wise, Stephen Y ^a   Ducey, Elizabeth J ^a   Fatanmi, Oluseyi O ^a   Elliott, Thomas B ^a   Singh, Vijay K ^a,b  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; COBALT 60; COLISTIN; DEOXYCHOLIC ACID; LYSINE; NALIDIXIC ACID; PUMA PROTEIN; XYLOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM CULTURE; CONTROLLED STUDY; CRYPT CELL; CULTURE MEDIUM; DIGESTIVE SYSTEM INJURY; DRUG EFFICACY; GAMMA RADIATION; HEART; INTESTINE CRYPT; INTESTINE VILLUS; JEJUNUM; LIVER; MALE; MITOSIS; MOUSE; MUSCLE REGENERATION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; SPLEEN; SURVIVAL TIME; WHOLE BODY RADIATION;

ALPHA-TOCOPHEROL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; MALE; MICE; RADIATION DOSAGE; RADIATION INJURIES; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; SURVIVAL RATE; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

BACTERIA (MICROORGANISMS); MUS; OVIS ARIES;

EID: 84856449143     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2627.1     Document Type: Article

References (64)

1. Benjamin GC, McGeary M, McCutchen SR. Assessing medical preparedness to respond to a terrorist nuclear event: Workshop report. Washington, DC: The National Academies Press; 2009.
2. Singh VK, Seed TM. Radiation effects. In: Roy MJ, editor. Physician's guide to terrorist attack. Totowa (NJ): Humana Press; 2003. p. 339-62.
3. Pellmar TC, Rockwell S. Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 2005; 163:115-23. (Pubitemid 40039952)
4. Williams JP, Brown SL, Georges GE, Hauer-Jensen M, Hill RP, Huser AK, et al. Animal models for medical countermeasures to radiation exposure. Radiat Res 2010; 173:557-78.
5. Koenig KL, Goans RE, Hatchett RJ, Mettler FA Jr, Schumacher TA, Noji EK, et al. Medical treatment of radiological casualties: current concepts. Ann Emerg Med 2005; 45:643-52. (Pubitemid 40812900)
6. Dainiak N. Hematologic consequences of exposure to ionizing radiation. Exp Hematol 2002; 30:513-28. (Pubitemid 34632623)
7. Drouet M, Herodin F. Radiation victim management and the haematologist in the future: time to revisit therapeutic guidelines? Int J Radiat Biol 2010; 86:636-48.
8. Waselenko JK, MacVittie TJ, Blakely WF, Pesik N, Wiley AL, Dickerson WE, et al. Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 2004; 140:1037-51.
9. Anno GH, Baum SJ, Withers HR, Young RW. Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. Health Phys 1989; 56:821-38. (Pubitemid 19139447)
10. Park E, Ahn G, Yun JS, Kim MJ, Bing SJ, Kim DS, et al. Dieckol rescues mice from lethal irradiation by accelerating hemopoiesis and curtailing immunosuppression. Int J Radiat Biol 2010; 86:848-59.
11. Park E, Ahn GN, Lee NH, Kim JM, Yun JS, Hyun JW, et al. Radioprotective properties of eckol against ionizing radiation in mice. FEBS Lett 2008; 582:925-30.
12. Weiss JF, Landauer MR. History and development of radiationprotective agents. Int J Radiat Biol 2009; 85:539-73.
13. MacVittie TJ, Farese AM. Cytokine-based treatment of radiation injury: potential benefits after low-level radiation exposure. Mil Med 2002; 167:68-70. (Pubitemid 34174189)
14. Weiss JF, Landauer MR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 2003; 189:1-20. (Pubitemid 36725020)
15. Packer L. Protective role of vitamin E in biological systems. Am J Clin Nutr 1991; 53:1050S-5S. (Pubitemid 21898873)
16. Noguchi N, Niki E. Chemistry of active oxygen species and antioxidants. In: Papas AM, editor. Antioxidant status, diet, nutrition, and health. Boca Raton (FL): CRC Press; 1999. p. 3-20.
17. Papas AM. Vitamin E: Tocopherols and tocotrienols. In: Papas AM, editor. Antioxidant status, diet, nutrition, and health. Boca Raton (FL): CRC Press; 1999. p. 189-210.
18. Desai D. Assay methods. In: Machlin L, editor. Vitamin E: A comprehensive treatise. New York: Marcel Dekker; 1980.
19. Singh VK, Brown DS, Kao TC. Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol 2009; 9:1423-30.
20. Singh VK, Brown DS, Kao TC. Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocytecolony stimulating factor. Int J Radiat Biol 2010; 86:12-21.
21. Singh VK, Brown DS, Kao TC, Seed TM. Preclinical development of a bridging therapy for radiation casualties. Exp Hematol 2010; 38:61-70.
22. Singh VK, Parekh VI, Brown DS, Kao TC, Mog SR. Tocopherol succinate: modulation of antioxidant enzymes and oncogene expression, and hematopoietic recovery. Int J Radiat Oncol Biol Phys 2011; 79:571-8.
23. Withers HR, Elkind MM. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1970; 17:261-7.
24. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293:293-7. (Pubitemid 32694744)
25. Qiu W, Carson-Walter EB, Liu H, Epperly M, Greenberger JS, Zambetti GP, et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2008; 2:576-83. (Pubitemid 351729214)
26. Bhanja P, Saha S, Kabarriti R, Liu L, Roy-Chowdhury N, Roy-Chowdhury J, et al. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS One 2009; 4:e8014.
27. Allison G. Nuclear disorder: surveying atomic threats. Foreign Affairs 2010; 89:74-89.
28. Seed TM. Radiation protectants: current status and future prospects. Health Phys 2005; 89:531-45. (Pubitemid 41463887)
29. Potten CS. A comprehensive study of the radiobiological response of the murine (BDF1) small intestine. Int J Radiat Biol 1990; 58:925-73.
30. Monti P, Wysocki J, van der Meeren A, Griffiths NM. The contribution of radiation-induced injury to the gastrointestinal tract in the development of multi-organ dysfunction syndrome or failure. BJR Suppl 2005; 27:89-94.
31. Dumont F, Le Roux A, Bischoff P. Radiation countermeasure agents: an update. Expert Opin Ther Pat 2010; 20:73-101.
32. Hosseinimehr SJ. Trends in the development of radioprotective agents. Drug Discov Today 2007; 12:794-805. (Pubitemid 47539965)
33. Eisbruch A. Amifostine in the treatment of head and neck cancer: intravenous administration, subcutaneous administration, or none of the above. J Clin Oncol 2011; 29:119-21.
34. Huang R, Yu H, Kuang A. Radioprotective effects on head and neck tumors of amifostine-a broad-spectrum cytoprotection. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2002; 19:708-11.
35. Landauer MR, Davis HD, Kumar KS, Weiss JF. Behavioral toxicity of selected radioprotectors. Adv Space Res 1992; 12:273-83.
36. Cassatt DR, Fazenbaker CA, Bachy CM, Hanson MS. Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy. Semin Radiat Oncol 2002; 12:97-102. (Pubitemid 34246077)
37. Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 2007; 12:738-47. (Pubitemid 47036208)
38. Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, et al. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 2009; 27:127-45.
39. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010; 15:360-71.
40. Meineke V, Fliedner TM. Radiation-induced multi-organ involvement and failure: challenges for radiation accident medical management and future research. BJR Suppl 2005; 27:196-200.
41. Hopewell JW. The skin: its structure and response to ionizing radiation. Int J Radiat Biol 1990; 57:751-73. (Pubitemid 20115272)
42. Li XH, Fu D, Latif NH, Mullaney CP, Ney PH, Mog SR, et al. Delta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signalregulated kinase/mammalian target of rapamycin signaling. Haematologica 2010; 95:1996-2004.
43. Ghosh SP, Kulkarni S, Hieber K, Toles R, Romanyukha L, Kao TC, et al. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Int J Radiat Biol 2009; 85:598-606.
44. Somosy Z, Horvath G, Telbisz A, Rez G, Palfia Z. Morphological aspects of ionizing radiation response of small intestine. Micron 2002; 33:167-78. (Pubitemid 32997017)
45. Berbee M, Fu Q, Boerma M, Wang J, Kumar KS, Hauer-Jensen M. gamma-Tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism. Radiat Res 2009; 171:596-605.
46. Mathieu J, Richard S, Ballester B, Chancerelle Y, Multon E. Apoptosis and gamma rays. Ann Pharm Fr 1999; 57:314-23.
47. Kim H, Tu HC, Ren D, Takeuchi O, Jeffers JR, Zambetti GP, et al. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. Mol Cell 2009; 36:487-99.
48. Qiu W, Leibowitz B, Zhang L, Yu J. Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene 2010; 29:1622-32.
49. Przybyszewski WM, Widel M, Szurko A, Maniakowski Z. [Dose rate-dependent cellular and molecular effects of ionizing radiation]. Postepy Hig Med Dosw 2008; 62:468-77.
50. Jindal A, Agrawal A, Goyal PK. Influence of Rosemarinus officinalis extract on radiation-induced intestinal injury in mice. J Environ Pathol Toxicol Oncol 2010; 29:169-79.
51. Rastogi L, Feroz S, Pandey BN, Jagtap A, Mishra KP. Protection against radiation-induced oxidative damage by an ethanolic extract of Nigella sativa L. Int J Radiat Biol 2010; 86:719-31.
52. Zhang R, Kang KA, Piao MJ, Ko DO, Wang ZH, Lee IK, et al. Eckol protects V79-4 lung fibroblast cells against gamma-ray radiation-induced apoptosis via the scavenging of reactive oxygen species and inhibiting of the c-Jun NH(2)-terminal kinase pathway. Eur J Pharmacol 2008; 591:114-23.
53. Ismail MS, Amer AS, Wahba O, Shalby H, Arian F. Effect of antioxidants on markers of apoptosis in postoperative radiotherapy of cancer cervix. Gulf J Oncolog 2010; Jan:8-13.
54. Kim KC, Lee IK, Kang KA, Kim BJ, Kim D, Moon JY, et al. Empetrum nigrum var. japonicum extract suppresses gamma-ray radiation-induced cell damage via inhibition of oxidative stress. Am J Chin Med 2011; 39:161-70.
55. Kiang JG, Smith JT, Agravante NG. Geldanamycin analog 17-DMAG inhibits iNOS and caspases in gamma-irradiated human T cells. Radiat Res 2009; 172:321-30.
56. Sharma D, Sandur SK, Rashmi R, Maurya DK, Suryavanshi S, Checker R, et al. Differential activation of NF-kappaB and nitric oxide in lymphocytes regulates in vitro and in vivo radiosensitivity. Mutat Res 2010; 703:149-57.
57. Brook I, Elliott TB, Ledney GD, Shoemaker MO, Knudson GB. Management of postirradiation infection: lessons learned from animal models. Mil Med 2004; 169:194-7. (Pubitemid 38338182)
58. Guzman-Stein G, Bonsack M, Liberty J, Delaney JP. Abdominal radiation causes bacterial translocation. J Surg Res 1989; 46:104-7. (Pubitemid 19066888)
59. Souba WW, Klimberg VS, Hautamaki RD, Mendenhall WH, Bova FC, Howard RJ, et al. Oral glutamine reduces bacterial translocation following abdominal radiation. J Surg Res 1990; 48:1-5. (Pubitemid 20042640)
60. Chun H, Sasaki M, Fujiyama Y, Bamba T. Effect of enteral glutamine on intestinal permeability and bacterial translocation after abdominal radiation injury in rats. J. Gastroenterol 1997; 32:189-95. (Pubitemid 27223081)
61. Schanaider A, Castro LS, Madi K. Effects of alpha-tocopherol on bacterial translocation and lipid peroxidation in rats with intestinal obstruction. Acta Cir Bras 2003; 18:283-8.
62. Sakaguchi S, Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol Med Microbiol 2006; 47:167-77. (Pubitemid 43881736)
63. Aruin LI. Helicobacter pylori infection is carcinogenic for humans. Arkh Patol 1997; 59:74-8. (Pubitemid 127518483)
64. Schimpl G, Pesendorfer P, Steinwender G, Feierl G, Ratschek M, Hollwarth ME. The effect of vitamin C and vitamin E supplementation on bacterial translocation in chronic portal hypertensive and common-bile-duct-ligated rats. Eur Surg Res 1997; 29:187-94. (Pubitemid 27196899)